This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
God is Brazilian: Turning Alcohol into Fuel
Giordano, Paola; Sanchez, Felix; Rahnema Alavi, AhmadCase SM-1654-EDecision Analysis, Innovation and Change, StrategyIn September 1979, while Brazil is treading the uncertain and dangerous waters of an oil crisis that has exacerbated the country's balance of payment, Mario Garnero, the president of the National Association of Automotive Vehicle Manufacturers (ANFAVEA), is desperately looking for an escape to avoid the imminent threat of gasoline rationing and to contain the oil dependency of his country. The idea of developing a local ethanol industry and to p...Starting at €8.20
-
God is Brazilian: Turning Alcohol Into Fuel (French Version)
Giordano, Paola; Sanchez, Felix; Rahnema Alavi, AhmadCase SM-1654-FRDecision Analysis, Innovation and Change, StrategyIn September 1979, while Brazil is treading the uncertain and dangerous waters of an oil crisis that has exacerbated the country's balance of payment, Mario Garnero, the president of the National Association of Automotive Vehicle Manufacturers (ANFAVEA), is desperately looking for an escape to avoid the imminent threat of gasoline rationing and to contain the oil dependency of his country. The idea of developing a local ethanol industry and to pr...Starting at €8.20
-
Comergent Technologies Inc.: Enterprise E-Commerce, Teaching Note
Rangan, V. Kasturi; Bellfor, MarieTeaching Note HBS-507087-EMarketingTeaching Note to (505-016). An abstract is not available for this product.Starting at €0.00
-
Gilead: Hepatitis-C Access Strategy (A)
Rangan, V. Kasturi; Rangan, Vikram; Bloom, David E.Case HBS-515025-EGilead had come up with an innovative drug for Hepatitis C, which affected 180 million people worldwide. The drug was priced at $1,000 a pill for the US market. Gilead had to decide how to price and market the pill in developing countries that bore the brunt of the disease. The company had earned accolades for its work in HIV/AIDS, where its innovative medicines now accounted for 60% of all patients on Anti-Retroviral (ARV) medicines. Much of thi...Starting at €8.20
-
Sanofi Pasteur: The Dengue Vaccine Dilemma
Rangan, V. Kasturi; Bloom, David E.; Dessain, Vincent; Billaud, EmilieCase HBS-514074-EIn 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a good balanced immune answer, it had a proof of efficacy of only 30%, far below the 70% mark the company had targeted. Guillaume Leroy, vice president of the Dengue Company at Sanofi Pa...Starting at €8.20
-
Centros Comerciales Pryca, S.A. - Teaching Note
Rahnema Alavi, AhmadTeaching Note FT-25-EFinanceNote prepared as an aid to instructors in the classroom use of case F-541-E.Starting at €0.00
-
Nokia's Growing Cash Mountain - Teaching Note
Mitchell, Jordan; Rahnema Alavi, AhmadTeaching Note FT-65-EFinanceNote prepared as an aid to instructors in the classroom use of case F-777-E.Starting at €0.00
-
Bitcoin: Deciphering the Crypto-currency
Zamora, Javier; Rahnema Alavi, Ahmad; Tatarinov, KatherineCase SI-191-EEntrepreneurship, Finance, Information TechnologiesBitcoin was one of the first implementations of a concept called crypto-currency. It was built on the notion that money can be any object or any sort of record accepted as payment for goods and services and repayment of debts in a given country or socio-economic context. Bitcoin was designed around the idea of a new form of money that used cryptography to control its creation and transactions, rather than relying on central authorities. In short,...Starting at €8.20
-
Ecu, El
Rahnema Alavi, AhmadTechnical Note FN-366FinanceEsta nota presenta una introducción al SME y sus mecanismos de cambio e intervención, como la parrilla de paridades y el indicador de divergencia. La nota analiza también los mercados del ECU y su futuro dentro de la unión económica y monetaria.Starting at €8.20
-
El microcrédito y las instituciones microfinancieras
Susaeta Erburu, Lourdes; Rahnema Alavi, AhmadTechnical Note FN-540FinanceEste documento trata de explicar el concepto de microfinanzas y microcrédito en sus distintas modalidades, las instituciones microfinancieras y los tres pilares del microcrédito: alcance, sostenibilidad financiera e impacto. El documento presenta varios casos reales de instituciones microfinancieras que están funcionando actualmente.Starting at €8.20